Biomarkers such as β-amyloid (Aβ), phosphorylated tau protein (p-tau), magnetic resonance imaging (MRI) and positron emission tomography (PET) are utilized to aid in the diagnosis of AD. This evidence concerns the gene MAPT and Alzheimer disease.